Basic features of hypoxic pulmonary vasoconstriction in mice

Respir Physiol Neurobiol. 2004 Jan 15;139(2):191-202. doi: 10.1016/j.resp.2003.10.003.

Abstract

Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion with ventilation which tends to optimize pulmonary gas exchange. Investigations using genetically engineered mice represent a promising approach to understand the underlying mechanisms. Our goal was to characterize basic features of HPV in the isolated buffer-perfused and ventilated mouse lung system. HPV was reproducible for several hours when ventilating the lungs with 1% O2 (10 min) alternated with normoxic ventilation periods (21% O2, 15 min). HPV was well elicitable and most constant using Krebs-Henseleit buffer with the addition of hydroxyethylamylopectin as an oncotic agent. Inhibition of both lung NO and prostanoid formation amplified HPV in an over-additive fashion. HPV was higher in BALB/c mive as compared to C57BL/6 mice, and was approximately threefold enhanced under positive pressure ventilation as compared to negative pressure ventilation. A three hour hypoxic ventilation period resulted in a biphasic vasoconstrictor response with loss of posthypoxic vasodilatation. In summary, we have characterised HPV and established an experimental set-up optimized for investigation of the basic mechanisms of HPV in mice.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Amylopectin / analogs & derivatives*
  • Amylopectin / metabolism
  • Animals
  • Aspirin / pharmacology
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Drug Interactions
  • Enzyme Inhibitors / pharmacology
  • Hypoxia / physiopathology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Oxygen / metabolism*
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / physiopathology*
  • Pulmonary Circulation / drug effects
  • Pulmonary Gas Exchange / physiology
  • Species Specificity
  • Tidal Volume / physiology
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology*
  • Vasoconstrictor Agents / pharmacology
  • omega-N-Methylarginine / pharmacology

Substances

  • Enzyme Inhibitors
  • Vasoconstrictor Agents
  • omega-N-Methylarginine
  • hydroxyethylamylopectin
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Amylopectin
  • Aspirin
  • Oxygen